"As a woman who watches how my family is… I take the difficult decisions": a qualitative study on integrated family planning and childhood immunisation services in five African countries.


Journal

Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380

Informations de publication

Date de publication:
15 Feb 2021
Historique:
received: 27 05 2020
accepted: 27 01 2021
entrez: 16 2 2021
pubmed: 17 2 2021
medline: 22 6 2021
Statut: epublish

Résumé

Family planning (FP) has the potential to improve maternal and child health outcomes and to reduce poverty in sub-Saharan Africa. However, substantial unmet need for modern contraceptive methods (MCMs) persists in this region. Current literature highlights multi-level barriers, including socio-cultural norms that discourage the use of MCMs. This paper explores women's choices and decision-making around MCM use and examines whether integrating FP services with childhood immunisations influenced women's perceptions of, and decision to use, an MCM. 94 semi-structured interviews and 21 focus group discussions with women, health providers, and community members (N = 253) were conducted in health facilities and outreach clinics where an intervention was delivering integrated FP and childhood immunisation services in Benin, Ethiopia, Kenya, Malawi and Uganda. Data were coded using Nvivo software and an analytical framework was developed to support interpretative and thematic analyses on women's decision-making about MCM use. Most women shared the reproductive desire to space or limit births because of the perceived benefits of improved health and welfare for themselves and for their children, including the economic advantages. For some, choices about MCM use were restricted because of wider societal influences. Women's decision to use MCMs was driven by their reproductive desires, but for some that was stymied by fears of side effects, community stigma, and disapproving husbands, which led to clandestine MCM use. Health providers acknowledged that women understood the benefits of using MCMs, but highlighted that the wider socio-cultural norms of their community often contributed to a reluctance to use them. Integration of FP and childhood immunisation services provided repeat opportunities for health providers to counter misinformation and it improved access to MCMs, including for women who needed to use them covertly. Some women chose to use MCMs without the approval of their husbands, and/or despite cultural norms, because of the perceived health and economic benefits for themselves and for their families, and because they lived with the consequences of short birth intervals and large families. Integrated FP and childhood immunisation services expanded women's choices about MCM use and created opportunities for women to make decisions autonomously.

Sections du résumé

BACKGROUND BACKGROUND
Family planning (FP) has the potential to improve maternal and child health outcomes and to reduce poverty in sub-Saharan Africa. However, substantial unmet need for modern contraceptive methods (MCMs) persists in this region. Current literature highlights multi-level barriers, including socio-cultural norms that discourage the use of MCMs. This paper explores women's choices and decision-making around MCM use and examines whether integrating FP services with childhood immunisations influenced women's perceptions of, and decision to use, an MCM.
METHODS METHODS
94 semi-structured interviews and 21 focus group discussions with women, health providers, and community members (N = 253) were conducted in health facilities and outreach clinics where an intervention was delivering integrated FP and childhood immunisation services in Benin, Ethiopia, Kenya, Malawi and Uganda. Data were coded using Nvivo software and an analytical framework was developed to support interpretative and thematic analyses on women's decision-making about MCM use.
RESULTS RESULTS
Most women shared the reproductive desire to space or limit births because of the perceived benefits of improved health and welfare for themselves and for their children, including the economic advantages. For some, choices about MCM use were restricted because of wider societal influences. Women's decision to use MCMs was driven by their reproductive desires, but for some that was stymied by fears of side effects, community stigma, and disapproving husbands, which led to clandestine MCM use. Health providers acknowledged that women understood the benefits of using MCMs, but highlighted that the wider socio-cultural norms of their community often contributed to a reluctance to use them. Integration of FP and childhood immunisation services provided repeat opportunities for health providers to counter misinformation and it improved access to MCMs, including for women who needed to use them covertly.
CONCLUSIONS CONCLUSIONS
Some women chose to use MCMs without the approval of their husbands, and/or despite cultural norms, because of the perceived health and economic benefits for themselves and for their families, and because they lived with the consequences of short birth intervals and large families. Integrated FP and childhood immunisation services expanded women's choices about MCM use and created opportunities for women to make decisions autonomously.

Identifiants

pubmed: 33588879
doi: 10.1186/s12978-021-01091-1
pii: 10.1186/s12978-021-01091-1
pmc: PMC7885443
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41

Références

Int Perspect Sex Reprod Health. 2015 Dec;41(4):191-9
pubmed: 26871727
Glob Health Action. 2015 Nov 09;8:29738
pubmed: 26562144
J Health Serv Res Policy. 2005 Jan;10(1):45-53
pubmed: 15667704
PLoS One. 2019 Jan 16;14(1):e0209602
pubmed: 30650085
Pan Afr Med J. 2016 Oct 17;25:78
pubmed: 28292041
BMC Public Health. 2020 Jun 5;20(1):865
pubmed: 32503485
BMC Public Health. 2015 Feb 10;15:118
pubmed: 25884675
Soc Sci Med. 2020 Aug;258:113086
pubmed: 32521413
BMC Health Serv Res. 2018 May 31;18(1):390
pubmed: 29855292
J Fam Plann Reprod Health Care. 2008 Jul;34(3):171-4
pubmed: 18577317
Contraception. 2018 Jul;98(1):41-46
pubmed: 29514043
BMC Public Health. 2011 May 19;11:342
pubmed: 21595897
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
Implement Sci. 2021 Jan 12;16(1):12
pubmed: 33435959
Stud Fam Plann. 1998 Dec;29(4):360-72
pubmed: 9919630
Stud Fam Plann. 2014 Jun;45(2):151-69
pubmed: 24931073
Glob Health Sci Pract. 2016 Jun 27;4(2):191-210
pubmed: 27353614
Lancet. 2012 Jul 14;380(9837):165-71
pubmed: 22784535
Pan Afr Med J. 2015 Jan 05;20:10
pubmed: 25995807
Glob Health Sci Pract. 2015 May 13;3(2):242-54
pubmed: 26085021
BMC Public Health. 2021 Jan 7;21(1):99
pubmed: 33413269
Reprod Health. 2014 Mar 05;11(1):21
pubmed: 24597502
Cult Health Sex. 2015;17(9):1132-46
pubmed: 26032620
Reprod Health. 2019 Jun 25;16(1):89
pubmed: 31238960
Health Place. 2012 Jul;18(4):766-73
pubmed: 22579117
Int Perspect Sex Reprod Health. 2010 Dec;36(4):189-96
pubmed: 21245025
Afr J Reprod Health. 2011 Jun;15(2):67-78
pubmed: 22590894

Auteurs

Jenna Hoyt (J)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. jenna.hoyt@lshtm.ac.uk.

Shari Krishnaratne (S)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Jessie K Hamon (JK)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Lydia Boudarene (L)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Tracey Chantler (T)

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.

Shiferaw Dechasa Demissie (SD)

International Rescue Committee Ethiopia Program, Addis Ababa, Ethiopia.

Justine Landegger (J)

International Rescue Committee US, New York, USA.

Easterlina Moseti (E)

World Vision International, Nairobi, Kenya.

Seth Marcus (S)

World Vision US, Monrovia, CA, USA.

Misozi Kambanje (M)

Save the Children International, Blantyre, Malawi.

Shannon Pryor (S)

Save the Children US, Washington, DC, USA.

Nathaly Spilotros (N)

International Rescue Committee US, New York, USA.

Marius Gnintoungbe (M)

Care Benin, Cotonou, Benin.

Dora Curry (D)

Care USA, Atlanta, USA.

Jayne Webster (J)

Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH